Coronary heart disease prevention; How much can we expect from cholesterol-lowering therapy?

被引：0

作者：

Fager, G ^{[1
]}

机构：

[1] GOTHENBURG UNIV,WALLENBERG LAB CARDIOVASC RES,GOTHENBURG,SWEDEN

来源：

ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期

关键词：

D O I：

10.1016/S0021-9150(97)88322-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：47 / 47

页数：1

共 50 条

[41] When to start cholesterol-lowering therapy in patients with coronary heart disease - A statement for healthcare professionals from the American heart association task force on risk reduction
Grundy, SM
Balady, GJ
Criqui, MH
Fletcher, G
Greenland, P
Hiratzka, LF
HoustonMiller, N
KrisEtherton, P
Krumholz, HM
LaRosa, J
Ockene, IS
Pearson, TA
Reed, J
Smith, SC
Washington, R
CIRCULATION, 1997, 95 (06) : 1683 - 1685
[42] CHOLESTEROL-LOWERING THERAPY IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
ANDERSON, TJ
MEREDITH, IT
YEUNG, AC
LIEBERMAN, EH
SELWYN, AP
GANZ, P
CIRCULATION, 1993, 88 (04) : 368 - 368
[43] Lipid-lowering therapy for the primary prevention of coronary heart disease
Gotto, AM
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) : 2078 - 2082
[44] Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe:: findings from EUROASPIRE study
Vanuzzo, D
Pilotto, L
Ambrosio, GB
Pyörälä, K
Lehto, S
De Bacquer, D
De Backer, G
Wood, D
ATHEROSCLEROSIS, 2000, 153 (02) : 505 - 517
[45] How much stock return predictability can we expect from an asset pricing model?
Zhou, Guofu
ECONOMICS LETTERS, 2010, 108 (02) : 184 - 186
[46] Cholesterol and prevention of coronary heart disease
Haq, IU
Jackson, PR
Yeo, WW
Ramsay, LE
LANCET, 1997, 349 (9046): : 210 - 211
[47] Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
Glasziou, PP
Eckermann, SD
Mulray, SE
Simes, RJ
Martin, AJ
Kirby, AC
Hall, JP
Caleo, S
White, HD
Tonkin, AM
MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (08) : 428 - 434
[48] Clinical implications of recent cholesterol lowering trials for the secondary prevention of coronary heart disease
Vogel, RA
AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 : S83 - S92
[49] Secondary prevention in coronary heart disease. Fact: Lowering cholesterol saves lives
McKenna, CJ
Sugrue, DD
IRISH MEDICAL JOURNAL, 1995, 88 (06) : 191 - 191
[50] THE FACT AND FICTION OF LOWERING CHOLESTEROL CONCENTRATIONS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE
CASTELLI, WP
BRITISH HEART JOURNAL, 1993, 69 (01): : S70 - S73

← 1 2 3 4 5 →